instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oral discomfort'. | Drug induced oral erythema multiforme: Case report.
BACKGROUND
Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations.
This artic... | DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 33907086 | 19,259,260 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oral disorder'. | Drug induced oral erythema multiforme: Case report.
BACKGROUND
Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations.
This artic... | DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 33907086 | 19,259,260 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sleep disorder'. | Drug induced oral erythema multiforme: Case report.
BACKGROUND
Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations.
This artic... | DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 33907086 | 19,259,260 | 2021-04-30 |
What was the administration route of drug 'DICLOFENAC'? | Drug induced oral erythema multiforme: Case report.
BACKGROUND
Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations.
This artic... | Oral | DrugAdministrationRoute | CC BY | 33907086 | 19,350,604 | 2021-04-30 |
What was the outcome of reaction 'Condition aggravated'? | Drug induced oral erythema multiforme: Case report.
BACKGROUND
Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations.
This artic... | Recovered | ReactionOutcome | CC BY | 33907086 | 19,259,260 | 2021-04-30 |
What was the outcome of reaction 'Dysphagia'? | Drug induced oral erythema multiforme: Case report.
BACKGROUND
Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations.
This artic... | Recovered | ReactionOutcome | CC BY | 33907086 | 19,259,260 | 2021-04-30 |
What was the outcome of reaction 'Erythema multiforme'? | Drug induced oral erythema multiforme: Case report.
BACKGROUND
Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations.
This artic... | Recovered | ReactionOutcome | CC BY | 33907086 | 19,350,604 | 2021-04-30 |
What was the outcome of reaction 'Lip scab'? | Drug induced oral erythema multiforme: Case report.
BACKGROUND
Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations.
This artic... | Recovered | ReactionOutcome | CC BY | 33907086 | 19,259,260 | 2021-04-30 |
What was the outcome of reaction 'Lip ulceration'? | Drug induced oral erythema multiforme: Case report.
BACKGROUND
Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations.
This artic... | Recovered | ReactionOutcome | CC BY | 33907086 | 19,259,260 | 2021-04-30 |
What was the outcome of reaction 'Oral discomfort'? | Drug induced oral erythema multiforme: Case report.
BACKGROUND
Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations.
This artic... | Recovered | ReactionOutcome | CC BY | 33907086 | 19,259,260 | 2021-04-30 |
What was the outcome of reaction 'Oral disorder'? | Drug induced oral erythema multiforme: Case report.
BACKGROUND
Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations.
This artic... | Recovered | ReactionOutcome | CC BY | 33907086 | 19,259,260 | 2021-04-30 |
What was the outcome of reaction 'Sleep disorder'? | Drug induced oral erythema multiforme: Case report.
BACKGROUND
Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations.
This artic... | Recovered | ReactionOutcome | CC BY | 33907086 | 19,259,260 | 2021-04-30 |
What was the administration route of drug 'DEXAMETHASONE SODIUM PHOSPHATE'? | Glycemic Profile of Intravenous Dexamethasone-Induced Hyperglycemia Using Continuous Glucose Monitoring.
BACKGROUND Intravenous (IV) dexamethasone is widely used in critical illness, chemotherapy, or severe COVID-19. Although glucocorticoid-induced hyperglycemia (GCIH) is well-known, there is no report describing the g... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33907174 | 19,460,175 | 2021-04-28 |
What was the administration route of drug 'DEXAMETHASONE'? | Glycemic Profile of Intravenous Dexamethasone-Induced Hyperglycemia Using Continuous Glucose Monitoring.
BACKGROUND Intravenous (IV) dexamethasone is widely used in critical illness, chemotherapy, or severe COVID-19. Although glucocorticoid-induced hyperglycemia (GCIH) is well-known, there is no report describing the g... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33907174 | 19,488,824 | 2021-04-28 |
What was the administration route of drug 'GEMCITABINE'? | Glycemic Profile of Intravenous Dexamethasone-Induced Hyperglycemia Using Continuous Glucose Monitoring.
BACKGROUND Intravenous (IV) dexamethasone is widely used in critical illness, chemotherapy, or severe COVID-19. Although glucocorticoid-induced hyperglycemia (GCIH) is well-known, there is no report describing the g... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33907174 | 19,488,824 | 2021-04-28 |
What was the administration route of drug 'PACLITAXEL'? | Glycemic Profile of Intravenous Dexamethasone-Induced Hyperglycemia Using Continuous Glucose Monitoring.
BACKGROUND Intravenous (IV) dexamethasone is widely used in critical illness, chemotherapy, or severe COVID-19. Although glucocorticoid-induced hyperglycemia (GCIH) is well-known, there is no report describing the g... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33907174 | 19,488,824 | 2021-04-28 |
What was the dosage of drug 'DEXAMETHASONE SODIUM PHOSPHATE'? | Glycemic Profile of Intravenous Dexamethasone-Induced Hyperglycemia Using Continuous Glucose Monitoring.
BACKGROUND Intravenous (IV) dexamethasone is widely used in critical illness, chemotherapy, or severe COVID-19. Although glucocorticoid-induced hyperglycemia (GCIH) is well-known, there is no report describing the g... | ON EVERY OTHER WEDNESDAY | DrugDosageText | CC BY-NC-ND | 33907174 | 19,460,175 | 2021-04-28 |
What was the dosage of drug 'REPAGLINIDE'? | Glycemic Profile of Intravenous Dexamethasone-Induced Hyperglycemia Using Continuous Glucose Monitoring.
BACKGROUND Intravenous (IV) dexamethasone is widely used in critical illness, chemotherapy, or severe COVID-19. Although glucocorticoid-induced hyperglycemia (GCIH) is well-known, there is no report describing the g... | BEFORE MEALS | DrugDosageText | CC BY-NC-ND | 33907174 | 19,488,824 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood bicarbonate decreased'. | Intestinal Perforation: A Rare Complication of Treatment With Bevacizumab.
Bevacizumab, a monoclonal immunoglobulin-G1 antibody directed against vascular endothelial growth factor (VEGF), inhibits angiogenesis. Gastrointestinal perforation is a serious and often fatal adverse event related to bevacizumab use. Bevacizum... | BEVACIZUMAB | DrugsGivenReaction | CC BY | 33907639 | 19,242,151 | 2021-03-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Intestinal Perforation: A Rare Complication of Treatment With Bevacizumab.
Bevacizumab, a monoclonal immunoglobulin-G1 antibody directed against vascular endothelial growth factor (VEGF), inhibits angiogenesis. Gastrointestinal perforation is a serious and often fatal adverse event related to bevacizumab use. Bevacizum... | BEVACIZUMAB | DrugsGivenReaction | CC BY | 33907639 | 19,242,151 | 2021-03-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Large intestine perforation'. | Intestinal Perforation: A Rare Complication of Treatment With Bevacizumab.
Bevacizumab, a monoclonal immunoglobulin-G1 antibody directed against vascular endothelial growth factor (VEGF), inhibits angiogenesis. Gastrointestinal perforation is a serious and often fatal adverse event related to bevacizumab use. Bevacizum... | BEVACIZUMAB | DrugsGivenReaction | CC BY | 33907639 | 19,242,151 | 2021-03-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Intestinal Perforation: A Rare Complication of Treatment With Bevacizumab.
Bevacizumab, a monoclonal immunoglobulin-G1 antibody directed against vascular endothelial growth factor (VEGF), inhibits angiogenesis. Gastrointestinal perforation is a serious and often fatal adverse event related to bevacizumab use. Bevacizum... | BEVACIZUMAB | DrugsGivenReaction | CC BY | 33907639 | 19,242,151 | 2021-03-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Troponin I increased'. | Intestinal Perforation: A Rare Complication of Treatment With Bevacizumab.
Bevacizumab, a monoclonal immunoglobulin-G1 antibody directed against vascular endothelial growth factor (VEGF), inhibits angiogenesis. Gastrointestinal perforation is a serious and often fatal adverse event related to bevacizumab use. Bevacizum... | BEVACIZUMAB | DrugsGivenReaction | CC BY | 33907639 | 19,242,151 | 2021-03-24 |
What was the administration route of drug 'BEVACIZUMAB'? | Intestinal Perforation: A Rare Complication of Treatment With Bevacizumab.
Bevacizumab, a monoclonal immunoglobulin-G1 antibody directed against vascular endothelial growth factor (VEGF), inhibits angiogenesis. Gastrointestinal perforation is a serious and often fatal adverse event related to bevacizumab use. Bevacizum... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33907639 | 19,242,151 | 2021-03-24 |
What was the dosage of drug 'BEVACIZUMAB'? | Intestinal Perforation: A Rare Complication of Treatment With Bevacizumab.
Bevacizumab, a monoclonal immunoglobulin-G1 antibody directed against vascular endothelial growth factor (VEGF), inhibits angiogenesis. Gastrointestinal perforation is a serious and often fatal adverse event related to bevacizumab use. Bevacizum... | 10 MILLIGRAM/KILOGRAM, Q2WK | DrugDosageText | CC BY | 33907639 | 19,242,151 | 2021-03-24 |
What was the outcome of reaction 'Death'? | Intestinal Perforation: A Rare Complication of Treatment With Bevacizumab.
Bevacizumab, a monoclonal immunoglobulin-G1 antibody directed against vascular endothelial growth factor (VEGF), inhibits angiogenesis. Gastrointestinal perforation is a serious and often fatal adverse event related to bevacizumab use. Bevacizum... | Fatal | ReactionOutcome | CC BY | 33907639 | 19,242,151 | 2021-03-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Clozapine Response for Vocal Tics in Schizophrenic Patients: A Case Report With Literature Review.
Antipsychotics have been documented in the literature as the most effective pharmacological treatment for tics thus far. Additionally, evidence in the literature has shown that typical and atypical antipsychotics are effe... | ARIPIPRAZOLE | DrugsGivenReaction | CC BY | 33907647 | 19,917,942 | 2021-03-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Extravasation'. | Tissue distribution of epirubicin after severe extravasation in humans.
As critical parameter after extravasation of cytotoxic vesicants, anthracyclines were determined in removed tissue from patients requiring surgical intervention due to tissue necrosis. We monitored their distribution within the affected lesion to e... | DOXORUBICIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33907881 | 19,260,693 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Necrosis'. | Tissue distribution of epirubicin after severe extravasation in humans.
As critical parameter after extravasation of cytotoxic vesicants, anthracyclines were determined in removed tissue from patients requiring surgical intervention due to tissue necrosis. We monitored their distribution within the affected lesion to e... | DOXORUBICIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33907881 | 19,260,693 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin necrosis'. | Tissue distribution of epirubicin after severe extravasation in humans.
As critical parameter after extravasation of cytotoxic vesicants, anthracyclines were determined in removed tissue from patients requiring surgical intervention due to tissue necrosis. We monitored their distribution within the affected lesion to e... | CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY | 33907881 | 19,397,374 | 2021-08 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Tissue distribution of epirubicin after severe extravasation in humans.
As critical parameter after extravasation of cytotoxic vesicants, anthracyclines were determined in removed tissue from patients requiring surgical intervention due to tissue necrosis. We monitored their distribution within the affected lesion to e... | UNK, CYCLIC | DrugDosageText | CC BY | 33907881 | 19,384,479 | 2021-08 |
What was the dosage of drug 'DOXORUBICIN HYDROCHLORIDE'? | Tissue distribution of epirubicin after severe extravasation in humans.
As critical parameter after extravasation of cytotoxic vesicants, anthracyclines were determined in removed tissue from patients requiring surgical intervention due to tissue necrosis. We monitored their distribution within the affected lesion to e... | 50 MG/M2, CYCLIC | DrugDosageText | CC BY | 33907881 | 19,384,479 | 2021-08 |
What was the dosage of drug 'PREDNISONE'? | Tissue distribution of epirubicin after severe extravasation in humans.
As critical parameter after extravasation of cytotoxic vesicants, anthracyclines were determined in removed tissue from patients requiring surgical intervention due to tissue necrosis. We monitored their distribution within the affected lesion to e... | UNK, CYCLIC | DrugDosageText | CC BY | 33907881 | 19,384,479 | 2021-08 |
What was the dosage of drug 'VINCRISTINE'? | Tissue distribution of epirubicin after severe extravasation in humans.
As critical parameter after extravasation of cytotoxic vesicants, anthracyclines were determined in removed tissue from patients requiring surgical intervention due to tissue necrosis. We monitored their distribution within the affected lesion to e... | UNK, CYCLIC | DrugDosageText | CC BY | 33907881 | 19,384,479 | 2021-08 |
What was the outcome of reaction 'Erythema'? | Tissue distribution of epirubicin after severe extravasation in humans.
As critical parameter after extravasation of cytotoxic vesicants, anthracyclines were determined in removed tissue from patients requiring surgical intervention due to tissue necrosis. We monitored their distribution within the affected lesion to e... | Recovered | ReactionOutcome | CC BY | 33907881 | 19,397,374 | 2021-08 |
What was the outcome of reaction 'Skin necrosis'? | Tissue distribution of epirubicin after severe extravasation in humans.
As critical parameter after extravasation of cytotoxic vesicants, anthracyclines were determined in removed tissue from patients requiring surgical intervention due to tissue necrosis. We monitored their distribution within the affected lesion to e... | Recovered | ReactionOutcome | CC BY | 33907881 | 19,397,374 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atelectasis'. | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | ACARBOSE, BISOPROLOL, CISPLATIN, FELODIPINE, GEMCITABINE\GEMCITABINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bronchial fistula'. | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | ACARBOSE, BISOPROLOL, CISPLATIN, FELODIPINE, GEMCITABINE\GEMCITABINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Emphysema'. | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | ACARBOSE, BISOPROLOL, CISPLATIN, FELODIPINE, GEMCITABINE\GEMCITABINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Empyema'. | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | ACARBOSE, BISOPROLOL, CISPLATIN, FELODIPINE, GEMCITABINE\GEMCITABINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Impaired healing'. | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | ACARBOSE, BISOPROLOL, CISPLATIN, FELODIPINE, GEMCITABINE\GEMCITABINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | ACARBOSE, BISOPROLOL, CISPLATIN, FELODIPINE, GEMCITABINE\GEMCITABINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | ACARBOSE, BISOPROLOL, CISPLATIN, FELODIPINE, GEMCITABINE\GEMCITABINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumothorax'. | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | ACARBOSE, BISOPROLOL, CISPLATIN, FELODIPINE, GEMCITABINE\GEMCITABINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | ACARBOSE, BISOPROLOL, CISPLATIN, FELODIPINE, GEMCITABINE\GEMCITABINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
What was the administration route of drug 'ACARBOSE'? | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | Oral | DrugAdministrationRoute | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
What was the administration route of drug 'BISOPROLOL'? | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | Oral | DrugAdministrationRoute | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
What was the administration route of drug 'FELODIPINE'? | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | Oral | DrugAdministrationRoute | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
What was the administration route of drug 'METFORMIN HYDROCHLORIDE'? | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | Oral | DrugAdministrationRoute | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
What was the dosage of drug 'CISPLATIN'? | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | 75 MG D1, D2 | DrugDosageText | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
What was the dosage of drug 'GEMCITABINE\GEMCITABINE HYDROCHLORIDE'? | Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review.
BACKGROUND
Bronchopleural fistula (BPF) is one of the most serious and rare postoperative complications, especially the bronchial stump fistula after lobectomy... | (1,250 MG/M2 D1+D8) | DrugDosageText | CC BY | 33910279 | 19,360,194 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Amino acid level decreased'. | Neonatal hyperinsulinism in transient and classical forms of tyrosinemia.
The spectrum of disorders associated with hyperinsulinemic hypoglycemia (HHI) has vastly increased over the past 20 years with identification of molecular, metabolic and cellular pathways involved in the regulation of insulin secretion and its ac... | NITISINONE | DrugsGivenReaction | CC BY | 33910593 | 20,391,523 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
BACKGROUND
Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are ass... | BUSULFAN, CEFOTAXIME SODIUM\SULBACTAM SODIUM, CYCLOPHOSPHAMIDE, CYCLOSPORINE, LEVOFLOXACIN, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, SEMUSTINE, TACROLIMUS | DrugsGivenReaction | CC BY | 33910622 | 19,588,464 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
BACKGROUND
Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are ass... | BUSULFAN, CEFOTAXIME SODIUM\SULBACTAM SODIUM, CYCLOPHOSPHAMIDE, CYCLOSPORINE, LEVOFLOXACIN, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, SEMUSTINE, TACROLIMUS | DrugsGivenReaction | CC BY | 33910622 | 19,588,464 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
BACKGROUND
Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are ass... | BUSULFAN, CEFOTAXIME SODIUM\SULBACTAM SODIUM, CYCLOPHOSPHAMIDE, CYCLOSPORINE, LEVOFLOXACIN, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, SEMUSTINE, TACROLIMUS | DrugsGivenReaction | CC BY | 33910622 | 19,588,464 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Klebsiella bacteraemia'. | Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
BACKGROUND
Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are ass... | BUSULFAN, CEFOTAXIME SODIUM\SULBACTAM SODIUM, CYCLOPHOSPHAMIDE, CYCLOSPORINE, LEVOFLOXACIN, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, SEMUSTINE, TACROLIMUS | DrugsGivenReaction | CC BY | 33910622 | 19,588,464 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Klebsiella infection'. | Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
BACKGROUND
Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are ass... | BUSULFAN, CEFOTAXIME SODIUM\SULBACTAM SODIUM, CYCLOPHOSPHAMIDE, CYCLOSPORINE, LEVOFLOXACIN, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, SEMUSTINE, TACROLIMUS | DrugsGivenReaction | CC BY | 33910622 | 19,588,464 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
BACKGROUND
Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are ass... | BUSULFAN, CEFOTAXIME SODIUM\SULBACTAM SODIUM, CYCLOPHOSPHAMIDE, CYCLOSPORINE, LEVOFLOXACIN, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, SEMUSTINE, TACROLIMUS | DrugsGivenReaction | CC BY | 33910622 | 19,588,464 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight decreased'. | Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
BACKGROUND
Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are ass... | BUSULFAN, CEFOTAXIME SODIUM\SULBACTAM SODIUM, CYCLOPHOSPHAMIDE, CYCLOSPORINE, LEVOFLOXACIN, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, SEMUSTINE, TACROLIMUS | DrugsGivenReaction | CC BY | 33910622 | 19,588,464 | 2021-04-28 |
What was the outcome of reaction 'Condition aggravated'? | Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
BACKGROUND
Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are ass... | Recovering | ReactionOutcome | CC BY | 33910622 | 19,588,464 | 2021-04-28 |
What was the outcome of reaction 'Febrile neutropenia'? | Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
BACKGROUND
Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are ass... | Recovered | ReactionOutcome | CC BY | 33910622 | 19,588,464 | 2021-04-28 |
What was the outcome of reaction 'Klebsiella bacteraemia'? | Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
BACKGROUND
Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are ass... | Recovering | ReactionOutcome | CC BY | 33910622 | 19,588,464 | 2021-04-28 |
What was the outcome of reaction 'Klebsiella infection'? | Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
BACKGROUND
Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are ass... | Recovering | ReactionOutcome | CC BY | 33910622 | 19,588,464 | 2021-04-28 |
What was the outcome of reaction 'Pneumonia'? | Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
BACKGROUND
Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are ass... | Recovering | ReactionOutcome | CC BY | 33910622 | 19,588,464 | 2021-04-28 |
What was the outcome of reaction 'Weight decreased'? | Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
BACKGROUND
Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are ass... | Recovered | ReactionOutcome | CC BY | 33910622 | 19,588,464 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthralgia'. | Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report.
BACKGROUND
Adjuvant endocrine therapy is recommended for the treatment of hormone-receptor-positive breast cancer. Aromatase inhibitors are associated with significant musculoskeletal adverse effects, likely through ... | ANASTROZOLE | DrugsGivenReaction | CC BY | 33910628 | 20,889,669 | 2021-04-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report.
BACKGROUND
Adjuvant endocrine therapy is recommended for the treatment of hormone-receptor-positive breast cancer. Aromatase inhibitors are associated with significant musculoskeletal adverse effects, likely through ... | ANASTROZOLE | DrugsGivenReaction | CC BY | 33910628 | 20,889,669 | 2021-04-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report.
BACKGROUND
Adjuvant endocrine therapy is recommended for the treatment of hormone-receptor-positive breast cancer. Aromatase inhibitors are associated with significant musculoskeletal adverse effects, likely through ... | ANASTROZOLE | DrugsGivenReaction | CC BY | 33910628 | 20,889,669 | 2021-04-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Musculoskeletal disorder'. | Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report.
BACKGROUND
Adjuvant endocrine therapy is recommended for the treatment of hormone-receptor-positive breast cancer. Aromatase inhibitors are associated with significant musculoskeletal adverse effects, likely through ... | ANASTROZOLE | DrugsGivenReaction | CC BY | 33910628 | 19,511,929 | 2021-04-29 |
What was the dosage of drug 'ANASTROZOLE'? | Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report.
BACKGROUND
Adjuvant endocrine therapy is recommended for the treatment of hormone-receptor-positive breast cancer. Aromatase inhibitors are associated with significant musculoskeletal adverse effects, likely through ... | UNKNOWN | DrugDosageText | CC BY | 33910628 | 19,511,929 | 2021-04-29 |
What was the outcome of reaction 'Arthralgia'? | Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report.
BACKGROUND
Adjuvant endocrine therapy is recommended for the treatment of hormone-receptor-positive breast cancer. Aromatase inhibitors are associated with significant musculoskeletal adverse effects, likely through ... | Recovered | ReactionOutcome | CC BY | 33910628 | 20,889,669 | 2021-04-29 |
What was the outcome of reaction 'Condition aggravated'? | Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report.
BACKGROUND
Adjuvant endocrine therapy is recommended for the treatment of hormone-receptor-positive breast cancer. Aromatase inhibitors are associated with significant musculoskeletal adverse effects, likely through ... | Recovered | ReactionOutcome | CC BY | 33910628 | 20,889,669 | 2021-04-29 |
What was the outcome of reaction 'Drug intolerance'? | Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report.
BACKGROUND
Adjuvant endocrine therapy is recommended for the treatment of hormone-receptor-positive breast cancer. Aromatase inhibitors are associated with significant musculoskeletal adverse effects, likely through ... | Recovered | ReactionOutcome | CC BY | 33910628 | 20,889,669 | 2021-04-29 |
What was the outcome of reaction 'Musculoskeletal disorder'? | Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report.
BACKGROUND
Adjuvant endocrine therapy is recommended for the treatment of hormone-receptor-positive breast cancer. Aromatase inhibitors are associated with significant musculoskeletal adverse effects, likely through ... | Recovered | ReactionOutcome | CC BY | 33910628 | 19,511,929 | 2021-04-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dermatitis acneiform'. | Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy.
Treatment of cancer with EGFR inhibitors is limited by on-target skin toxicities induced by inhibition of the MAPK pathway. BRAF inhibitors are known to paradoxically activate the MAPK downstream of EGFR, which we confirmed using human s... | PANITUMUMAB | DrugsGivenReaction | CC BY-NC-ND | 33910927 | 19,237,758 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy.
Treatment of cancer with EGFR inhibitors is limited by on-target skin toxicities induced by inhibition of the MAPK pathway. BRAF inhibitors are known to paradoxically activate the MAPK downstream of EGFR, which we confirmed using human s... | PANITUMUMAB | DrugsGivenReaction | CC BY-NC-ND | 33910927 | 19,236,395 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary toxicity'. | Two Limitations of Subcutaneous Implantable Cardioverter Defibrillator in the Same Patient Warranting Its Explant.
BACKGROUND A subcutaneous implantable cardioverter defibrillator (S-ICD) is preferred over a transvenous implantable cardioverter defibrillator (TV-ICD) in selected cases owing to a lower rate of lead-rela... | AMIODARONE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33911064 | 20,187,113 | 2021-04-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac death'. | Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy.
Multifocal motor neuropathy (MMN) is a rare disease with a prevalence of less than 1 per 100,000 people. Intravenous immunoglobulin (IVIG) therapy, performed for a long-term period, has been demonstrated able to improve the clinical pi... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY | 33911162 | 19,235,254 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral venous sinus thrombosis'. | Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy.
Multifocal motor neuropathy (MMN) is a rare disease with a prevalence of less than 1 per 100,000 people. Intravenous immunoglobulin (IVIG) therapy, performed for a long-term period, has been demonstrated able to improve the clinical pi... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY | 33911162 | 19,302,224 | 2021-04-28 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy.
Multifocal motor neuropathy (MMN) is a rare disease with a prevalence of less than 1 per 100,000 people. Intravenous immunoglobulin (IVIG) therapy, performed for a long-term period, has been demonstrated able to improve the clinical pi... | Subcutaneous | DrugAdministrationRoute | CC BY | 33911162 | 19,302,224 | 2021-04-28 |
What was the outcome of reaction 'Cardiac death'? | Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy.
Multifocal motor neuropathy (MMN) is a rare disease with a prevalence of less than 1 per 100,000 people. Intravenous immunoglobulin (IVIG) therapy, performed for a long-term period, has been demonstrated able to improve the clinical pi... | Fatal | ReactionOutcome | CC BY | 33911162 | 19,235,254 | 2021-04-28 |
What was the outcome of reaction 'Cerebral venous sinus thrombosis'? | Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy.
Multifocal motor neuropathy (MMN) is a rare disease with a prevalence of less than 1 per 100,000 people. Intravenous immunoglobulin (IVIG) therapy, performed for a long-term period, has been demonstrated able to improve the clinical pi... | Recovered | ReactionOutcome | CC BY | 33911162 | 19,302,224 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foreign body in gastrointestinal tract'. | Body Packer Syndrome.
"Body packers" are persons who voluntarily or through coercion, swallow or insert drug-filled packets into body cavity, generally in an attempt to smuggle them across secure borders. The drugs most often involved in body packing are heroin and cocaine. Body packers can present in the emergency dep... | MORPHINE SULFATE | DrugsGivenReaction | CC BY-NC-SA | 33911438 | 19,173,770 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Body Packer Syndrome.
"Body packers" are persons who voluntarily or through coercion, swallow or insert drug-filled packets into body cavity, generally in an attempt to smuggle them across secure borders. The drugs most often involved in body packing are heroin and cocaine. Body packers can present in the emergency dep... | MORPHINE SULFATE | DrugsGivenReaction | CC BY-NC-SA | 33911438 | 19,173,770 | 2021 |
What was the outcome of reaction 'Toxicity to various agents'? | Body Packer Syndrome.
"Body packers" are persons who voluntarily or through coercion, swallow or insert drug-filled packets into body cavity, generally in an attempt to smuggle them across secure borders. The drugs most often involved in body packing are heroin and cocaine. Body packers can present in the emergency dep... | Recovering | ReactionOutcome | CC BY-NC-SA | 33911438 | 19,173,770 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Heparin-induced thrombocytopenia'. | Positive SARS-CoV-2 RNA with Significant Inflammatory State and Thrombophilia after 12 Weeks of Initial Diagnosis of COVID-19 Infection.
The ongoing COVID-19 pandemic has affected most countries in the world, with significant economic and public health implications. There is rising concern that patients who recover fro... | APIXABAN, HEPARIN SODIUM | DrugsGivenReaction | CC BY-NC-SA | 33911453 | 19,109,769 | 2021 |
What was the dosage of drug 'APIXABAN'? | Positive SARS-CoV-2 RNA with Significant Inflammatory State and Thrombophilia after 12 Weeks of Initial Diagnosis of COVID-19 Infection.
The ongoing COVID-19 pandemic has affected most countries in the world, with significant economic and public health implications. There is rising concern that patients who recover fro... | DRIP | DrugDosageText | CC BY-NC-SA | 33911453 | 19,109,769 | 2021 |
What was the dosage of drug 'HEPARIN SODIUM'? | Positive SARS-CoV-2 RNA with Significant Inflammatory State and Thrombophilia after 12 Weeks of Initial Diagnosis of COVID-19 Infection.
The ongoing COVID-19 pandemic has affected most countries in the world, with significant economic and public health implications. There is rising concern that patients who recover fro... | DRIP (INSTITUTION WEIGHT?BASED INFUSION PROTOCOL) | DrugDosageText | CC BY-NC-SA | 33911453 | 19,109,769 | 2021 |
What was the outcome of reaction 'Heparin-induced thrombocytopenia'? | Positive SARS-CoV-2 RNA with Significant Inflammatory State and Thrombophilia after 12 Weeks of Initial Diagnosis of COVID-19 Infection.
The ongoing COVID-19 pandemic has affected most countries in the world, with significant economic and public health implications. There is rising concern that patients who recover fro... | Recovered | ReactionOutcome | CC BY-NC-SA | 33911453 | 19,109,769 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematuria'. | Segmental Arterial Mediolysis (SAM) Leading to Chronic Renal Insufficiency.
Segmental arterial mediolysis (SAM) is a rare self-limiting non-atherosclerotic, non-inflammatory vasculopathy. SAM typically affects the visceral arteries of the abdomen to include the celiac, mesenteric, and renal arteries. SAM has a favorabl... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 33911893 | 20,119,367 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Sacubitril/Valsartan to Treat Heart Failure in a Patient with Relapsing Hairy Cell Leukaemia: Case Report.
Experience with angiotensin-receptor neprilysin inhibitors (ARNI) in oncologic patients with heart failure (HF) is limited. We report a case of ARNI started as first-choice therapy in a patient with relapsing hair... | CLADRIBINE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 33911910 | 19,624,674 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Sacubitril/Valsartan to Treat Heart Failure in a Patient with Relapsing Hairy Cell Leukaemia: Case Report.
Experience with angiotensin-receptor neprilysin inhibitors (ARNI) in oncologic patients with heart failure (HF) is limited. We report a case of ARNI started as first-choice therapy in a patient with relapsing hair... | CLADRIBINE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 33911910 | 19,624,674 | 2021 |
What was the dosage of drug 'CLADRIBINE'? | Sacubitril/Valsartan to Treat Heart Failure in a Patient with Relapsing Hairy Cell Leukaemia: Case Report.
Experience with angiotensin-receptor neprilysin inhibitors (ARNI) in oncologic patients with heart failure (HF) is limited. We report a case of ARNI started as first-choice therapy in a patient with relapsing hair... | 0.09 MG/KG FOR 7 DAYS | DrugDosageText | CC BY-NC | 33911910 | 19,624,674 | 2021 |
What was the dosage of drug 'RITUXIMAB'? | Sacubitril/Valsartan to Treat Heart Failure in a Patient with Relapsing Hairy Cell Leukaemia: Case Report.
Experience with angiotensin-receptor neprilysin inhibitors (ARNI) in oncologic patients with heart failure (HF) is limited. We report a case of ARNI started as first-choice therapy in a patient with relapsing hair... | 8 CYCLES OF 375 ML/M2 | DrugDosageText | CC BY-NC | 33911910 | 19,624,674 | 2021 |
What was the outcome of reaction 'Cardiac failure'? | Sacubitril/Valsartan to Treat Heart Failure in a Patient with Relapsing Hairy Cell Leukaemia: Case Report.
Experience with angiotensin-receptor neprilysin inhibitors (ARNI) in oncologic patients with heart failure (HF) is limited. We report a case of ARNI started as first-choice therapy in a patient with relapsing hair... | Recovered | ReactionOutcome | CC BY-NC | 33911910 | 19,624,674 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Accidental overdose'. | Case Report: Multiple Seizures After a Diphenoxylate-Atropine Overdose in a Small Child.
Poisoning is a type of accidental injury and it is considered a major public health problem worldwide. Oral drug poisoning in children is an important cause of accidental injury and even death. It is a common critical emergency in ... | ATROPINE | DrugsGivenReaction | CC BY | 33912057 | 19,685,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Encephalopathy'. | Case Report: Multiple Seizures After a Diphenoxylate-Atropine Overdose in a Small Child.
Poisoning is a type of accidental injury and it is considered a major public health problem worldwide. Oral drug poisoning in children is an important cause of accidental injury and even death. It is a common critical emergency in ... | ATROPINE | DrugsGivenReaction | CC BY | 33912057 | 19,685,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Focal dyscognitive seizures'. | Case Report: Multiple Seizures After a Diphenoxylate-Atropine Overdose in a Small Child.
Poisoning is a type of accidental injury and it is considered a major public health problem worldwide. Oral drug poisoning in children is an important cause of accidental injury and even death. It is a common critical emergency in ... | ATROPINE | DrugsGivenReaction | CC BY | 33912057 | 19,685,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Generalised tonic-clonic seizure'. | Case Report: Multiple Seizures After a Diphenoxylate-Atropine Overdose in a Small Child.
Poisoning is a type of accidental injury and it is considered a major public health problem worldwide. Oral drug poisoning in children is an important cause of accidental injury and even death. It is a common critical emergency in ... | ATROPINE | DrugsGivenReaction | CC BY | 33912057 | 19,685,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory arrest'. | Case Report: Multiple Seizures After a Diphenoxylate-Atropine Overdose in a Small Child.
Poisoning is a type of accidental injury and it is considered a major public health problem worldwide. Oral drug poisoning in children is an important cause of accidental injury and even death. It is a common critical emergency in ... | ATROPINE | DrugsGivenReaction | CC BY | 33912057 | 19,685,657 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.